Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,333 public trials 507 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NCT06270706

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumor, +64 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • South Texas Accelerated Research Therapeutics (START) Grand Rapids, Michigan, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic (Arizona) Scottsdale, Arizona, United States
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 82 locations
View Trial Details
Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

NCT03877796

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of New Mexico Comprehensive Cancer Albuquerque, New Mexico, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University Medical Center Cancer Center Lubbock, Texas, United States
View Trial Details
Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT06161025

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Sylvester Comprehensive Cancer Center at Lennar Coral Gables, Florida, United States
  • Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
View all 164 locations
View Trial Details
Recruiting

AOH1996 for the Treatment of Refractory Solid Tumors

NCT05227326

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +39 more
Locations
  • Honor Health Research and Innovation Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Recruiting

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT05460000

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinik Innsbruck Innsbruck, Austria
  • Cliniques Universitaires St. Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • Jessa ziekenhuis Hasselt, Belgium
View all 50 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details

Related conditions